8-K ·Filed Jul 20, 2026
8-K context-dependent: Items 8.01
Actionable Insight • Neutral
Routine personnel change with no financial or operational implications — no trading action warranted. Monitor for any future filings that might indicate a broader organizational shift.
Final — all horizons settled through T+60d
IMMX ▼ -1.25% at T+60d
NEUTRAL call -1.25% · α vs SPY -6.09% · entry $8.80 → $8.69
T+1d
+8.75%
call +8.75% · α +7.92%
$9.57
settled 3mo ago
T+5d
-3.18%
call -3.18% · α -2.76%
$8.52
settled 3mo ago
T+20d
+28.86%
call +28.86% · α +24.74%
$11.34
settled 2mo ago
T+60d
-1.25%
call -1.25% · α -6.09%
$8.69
settled 14d ago
Price Chart
Loading chart...
Executive Summary
Immix Biopharma filed an 8-K reporting the termination of Richard Graydon effective July 17, 2026, for reasons unrelated to his company activities. Management states the short-tenured departure has no material effect on the business.
Key Facts
- Richard Graydon terminated effective July 17, 2026
- Reasons unrelated to his activities at the company
- Management believes no material effect on business due to short tenure
Financial Impact
No financial impact disclosed
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-033829 |
| Document: 0001493152-26-033829-index-headers.html | 0001493152-26-033829 |
| Document: 0001493152-26-033829-index.html | 0001493152-26-033829 |
| Document: 0001493152-26-033829.txt | 0001493152-26-033829 |
6 reports for IMMX
60% Hit rate @ T+5 Went positive at some point 3 of 5 best @ T+60▲ +30.80%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 26d ago | 8-K | $10.23 $9.29 | ▲ +9.19% | ▲ +10.49% | $7.99 (+21.95%) |
Sep 29, 2026 28d ago | 424B5 | $10.54 $9.64 | ▲ +8.54% | ▲ +10.49% | $7.99 (+24.24%) |
Sep 29, 2026 28d ago | 8-K | $10.54 $9.64 | ▼ −8.54% | ▼ −10.49% | $7.99 (−24.24%) |
Jul 20, 2026 14w ago | 8-K | $8.80 $8.52 | ▼ −3.18% | ▼ −2.76% | $7.99 (−9.26%) |
May 21, 2026 22w ago | 8-K | $8.78 $9.22 | ▼ −5.01% | ▼ −3.35% | $7.99 (+9.05%) |
May 21, 2026 22w ago | Press Release | $8.67 $9.00 | ▲ +3.81% | ▲ +1.96% | $7.99 (−7.90%) |
Showing 6 of 6
US Market Status
Market Open — Closes in 4h 15m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers